Hypertensive crisis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(26 intermediate revisions by 9 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{| class="infobox" style="float:right;"
|-
| [[File:Siren.gif|30px|link=Stroke resident survival guide]]|| <br> || <br>
| [[Hypertensive crisis resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']]
|}
{{SI}}
{{SI}}
{{CMG}}; {{AE}} {{AN}}
{{CMG}}; {{AE}} {{AN}}


{{SK}} Hypertensive crisis; hypertensive urgency; severe hypertension
{{SK}} Hypertensive emergency; hypertensive urgency; severe hypertension


==Overview==
==Overview==
A '''hypertensive emergency''' is severe [[hypertension]] with acute impairment of an [[organ system]] (especially the [[central nervous system]], [[cardiovascular system]] and/or the [[renal system]]) and the possibility of irreversible organ-damage. In case of a hypertensive emergency, the [[blood pressure]] should be lowered aggressively over minutes to hours with an [[antihypertensive]] agent.
Hypertensive crisis is a term used to describe a severe elevation in the [[blood pressure]] which may or may not be associated with end-organ damage.<ref name="-1993">{{Cite journal  | title = The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) | journal = Arch Intern Med | volume = 153 | issue = 2 | pages = 154-83 | month = Jan | year = 1993 | doi =  | PMID = 8422206 }}</ref>  Noncompliance with [[hypertension medical therapy|antihypertensive medications]] is the most common cause of hypertensive crisis.<ref name="Stewart-2006">{{Cite journal  | last1 = Stewart | first1 = DL. | last2 = Feinstein | first2 = SE. | last3 = Colgan | first3 = R. | title = Hypertensive urgencies and emergencies. | journal = Prim Care | volume = 33 | issue = 3 | pages = 613-23, v | month = Sep | year = 2006 | doi = 10.1016/j.pop.2006.06.001 | PMID = 17088151 }}</ref>  Hypertensive crisis includes both hypertensive emergency and hypertensive urgency.  Hypertensive urgency is the severe elevation in the [[blood pressure]] without any evidence of acute end-organ damage.  Hypertensive emergency mostly falls into stage 2 of hypertension.  It is usually the severe elevation in the [[blood pressure]] (systolic blood pressure >180 mm Hg, or diastolic blood pressure >120 mm Hg) complicated by acute end-organ dysfunction, such as [[hypertensive encephalopathy]], [[eclampsia]], [[dissecting aortic aneurysm]], [[Congestive heart failure classification#Acute or Decompensated|acute left ventricular failure]] with [[pulmonary edema]], [[acute myocardial infarction]], [[acute renal failure]], or symptomatic [[microangiopathic hemolytic anemia]].<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199  }} </ref>  The treatment of hypertensive urgency requires a gradual reduction in blood pressure over 24 to 48 hours.  In hypertensive emergency,  the treatment should be targeted to reduce the blood pressure by not more than 25% within the first hour; when blood pressure is stable, it should be reduced to 160/100-110 mmHg within the next 2 to 6 hours.<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199  }} </ref>
 
==Classification==
Hypertensive crisis can be further classified as hypertensive urgency and hypertensive emergency based on either the absence or presence of acute end-organ damage.<ref name="-1993">{{Cite journal  | title = The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) | journal = Arch Intern Med | volume = 153 | issue = 2 | pages = 154-83 | month = Jan | year = 1993 | doi =  | PMID = 8422206 }}</ref>
 
{{Familytree/start}}
{{Familytree | | | A01 | | A01= '''[[Hypertensive crisis]]''' <br> ''Acute elevation of blood pressure''<br> - Systolic blood pressure >180 mm Hg, or <br> - Diastolic blood pressure >120 mm Hg}}
{{Familytree | |,|-|^|-|.| }}
{{Familytree | B01 | | B02 | | B01= '''[[Hypertensive emergency]]''' <br>
Evidence of end organ damage
| B02= '''[[Hypertensive urgency]]'''<br>
No evidence of end organ damage }}
{{Familytree/end}}
 
===Hypertensive Urgency===
Hypertensive urgency is an acute severe elevation in the [[blood pressure]] without any evidence of acute end-organ damage.
 
===Hypertensive Emergency===
Hypertensive emergency mostly falls into stage 2 of hypertension (systolic blood pressure greater >160 mm Hg or diastolic blood pressure >100 mm Hg).  It is usually an acute severe elevation in the [[blood pressure]] (systolic blood pressure >180 mm Hg, or diastolic blood pressure >120 mm Hg) complicated by acute end-organ dysfunction, such as [[hypertensive encephalopathy]], [[eclampsia]], [[dissecting aortic aneurysm]], [[Congestive heart failure classification#Acute or Decompensated|acute left ventricular failure]] with [[pulmonary edema]], [[acute myocardial infarction]], [[acute renal failure]], or symptomatic [[microangiopathic hemolytic anemia]].<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199  }} </ref>
 
==== Hypertensive Emergency as a Specific Term ====
The term hypertensive emergency is primarily used as a specific term for a hypertensive crisis with a [[diastolic blood pressure]] of 120 mm Hg and above plus end organ damage (brain, [[cardiovascular]], [[renal]]) (as described above) in contrast to hypertensive urgency where as yet no end organ damage has developed. The former requires immediate lowering of [[blood pressure]] such as with [[sodium nitroprusside]] [[infusion]]s (NOT [[injection]]s) while urgencies (about 3/4 of cases with [[diastolic blood pressure]] of 120 mm Hg and above) can be treated with [[parenteral]] administration (NOT oral) of [[labetalol]] or some [[calcium channel blockers]]. The former use of oral [[nifedipine]], a [[calcium channel blocker|calcium channel antagonist]], has been strongly discouraged or banned because it is not absorbed in a controlled and reproducible fashion and has led to serious and fatal [[hypotension|hypotensive]] problems.
 
==== Hypertensive Emergency as a Generic Term ====
Sometimes, although not very often, the term hypertensive emergency is also used as a generic term, comprising both hypertensive emergency as a specific term for a serious and urgent condition of elevated [[blood pressure]] and hypertensive urgency as a specific term of a less serious and less urgent condition (the terminology hypertensive crisis is usually used in this sense).
 
==Causes==
===Life Threatening Causes===
[[Hypertensive crisis]] is a life-threatening condition and must be treated as such irrespective of the cause.
 
===Common Causes===
* [[Hypertension medical therapy|Antihypertensive medications]] withdrawal ( [[beta blocker]]s, [[clonidine]])
* Noncompliance with [[hypertension medical therapy|antihypertensive medications]]<ref name="Stewart-2006">{{Cite journal  | last1 = Stewart | first1 = DL. | last2 = Feinstein | first2 = SE. | last3 = Colgan | first3 = R. | title = Hypertensive urgencies and emergencies. | journal = Prim Care | volume = 33 | issue = 3 | pages = 613-23, v | month = Sep | year = 2006 | doi = 10.1016/j.pop.2006.06.001 | PMID = 17088151 }}</ref>
* [[Pheochromocytoma]]
* Side effects of [[monoamine oxidase inhibitor]]s
* [[Stimulants]] ([[cocaine]], [[methamphetamine]], [[phencyclidine]])
* [[Phenylephrine]]
 
===Causes by Organ System===
{|style="width:80%; height:100px" border="1"
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular'''
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | No underlying causes
|-
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Dental'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Dermatologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Axitinib]], [[Naphazoline]], [[Naratriptan]], [[Phendimetrazine]], [[Sorafenib]] , [[Ziv-aflibercept]]  
|-
|-bgcolor="LightSteelBlue"
| '''Ear Nose Throat'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Endocrine'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Environmental'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Gastroenterologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Genetic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Hematologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Iatrogenic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Infectious Disease'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Musculoskeletal/Orthopedic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Neurologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Nutritional/Metabolic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Obstetric/Gynecologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Oncologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Ophthalmologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Overdose/Toxicity'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Psychiatric'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Pulmonary'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Renal/Electrolyte'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Rheumatology/Immunology/Allergy'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Sexual'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Trauma'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Urologic'''
|bgcolor="Beige"| No underlying causes
|-
|-bgcolor="LightSteelBlue"
| '''Miscellaneous'''
|bgcolor="Beige"| No underlying causes
|-
|}
 
===Causes in Alphabetical Order===
: List the causes of the disease in alphabetical order. You may need to list across the page, as seen [[Jaundice causes#Causes in Alphabetical Order|here]]
{{col-begin|width=80%}}
{{col-break|width=33%}}
*[[Naratriptan]]
*[[Sorafenib]]
 
{{col-break|width=33%}}
 
 
{{col-break|width=33%}}
 
{{col-end}}


==Treatment==
==Treatment==
Several classes of antihypertensive agents are recommended and the choice for the antihypertensive agent depends on the cause for the hypertensive crisis, the severity of elevated blood pressure and the patients usual blood pressure before the hypertensive crisis. In most cases, the administration of an [[intravenous]] [[sodium nitroprusside]] [[Injection (medicine)|injection]] which has an almost immediate [[antihypertensive]] effect is suitable but in many cases not readily available. In less urgent cases, oral agents like [[captopril]], [[clonidine]], [[labetalol]], [[prazosin]], which have all a delayed onset of action by several minutes compared to sodium nitroprusside, can also be used.
Management is directed by [[clinical practice guideline]]s<ref name="pmid29133356">{{cite journal| author=Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C | display-authors=etal| title=2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | journal=Hypertension | year= 2018 | volume= 71 | issue= 6 | pages= e13-e115 | pmid=29133356 | doi=10.1161/HYP.0000000000000065 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29133356  }} </ref>:
* "Hypertensive emergencies are defined as severe elevations in BP (>180/120 mm Hg) associated with evidence of new or worsening target organ damage."
* "hypertensive urgencies are situations associated with severe BP elevation in otherwise stable patients without acute or impending change in target organ damage or dysfunction....Reinstitution or intensification of antihypertensive drug therapy and treatment of anxiety as applicable. There is no indication for referral to the emergency department, immediate reduction in BP in the emergency department, or hospitalization for such patients"
 
===Provide acute therapy for hypertensive ''emergency''===
For patients with end-organ damage and [[SBP]] >179 and [[DBP]] >119, the patient is suffering from [[hypertensive emergency]]. These patients should be admitted to the ICU and receive parenteral antihypertensive medications to avoid fluctuating drug levels from the oral or intramuscular routes.  The immediate goal is to decrease the DBP by 10-15 % or to approximately 110 mm Hg in the first 30-60 minutes, then when blood pressure is stable, reduce to 160/100-110 mmHg within the next 2-6 hours. Start the treatment with short-acting IV antihypertensive drugs depending on the type of the end-organ damage. Keep close monitoring to the [[blood pressure]] and in severely ill patients intra-arterial [[blood pressure]] monitoring is used. Once the [[blood pressure]] is stable we shift to oral antihypertensive drugs. When the patient is stable and the [[blood pressure]] is well tolerated, reduce the [[blood pressure]] to normal within 24-48 hours.
 
===Increase chronic therapy for hypertensive ''urgency''===
 
Per the 2018 multi-society practice guideline:
* "hypertensive urgencies ... are treated by reinstitution or intensification of antihypertensive drug therapy"<ref name="pmid29133356">{{cite journal| author=Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C | display-authors=etal| title=2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. | journal=Hypertension | year= 2018 | volume= 71 | issue= 6 | pages= e13-e115 | pmid=29133356 | doi=10.1161/HYP.0000000000000065 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29133356  }} </ref>
 
Evidence for this approach exists<ref name="pmid2679473">{{cite journal| author=Zeller KR, Von Kuhnert L, Matthews C| title=Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial. | journal=Arch Intern Med | year= 1989 | volume= 149 | issue= 10 | pages= 2186-9 | pmid=2679473 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=clinical.uthscsa.edu/cite&email=badgett@uthscdsa.edu&retmode=ref&cmd=prlinks&id=2679473 }}</ref><ref name="pmid4862069">{{cite journal| author=| title=Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. | journal=JAMA | year= 1967 | volume= 202 | issue= 11 | pages= 1028-34 | pmid=4862069 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4862069  }} </ref>
 
Intensifying treatment of hospitalized patients in the absence of emergency may worse outcomes, at least for noncardiac patients<ref name="pmid33369614">{{cite journal| author=Rastogi R, Sheehan MM, Hu B, Shaker V, Kojima L, Rothberg MB| title=Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions. | journal=JAMA Intern Med | year= 2021 | volume= 181 | issue= 3 | pages= 345-352 | pmid=33369614 | doi=10.1001/jamainternmed.2020.7501 | pmc=7770615 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33369614  }} </ref><ref name="pmid31424475">{{cite journal| author=Anderson TS, Jing B, Auerbach A, Wray CM, Lee S, Boscardin WJ | display-authors=etal| title=Clinical Outcomes After Intensifying Antihypertensive Medication Regimens Among Older Adults at Hospital Discharge. | journal=JAMA Intern Med | year= 2019 | volume= 179 | issue= 11 | pages= 1528-1536 | pmid=31424475 | doi=10.1001/jamainternmed.2019.3007 | pmc=6705136 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31424475  }} </ref>. However, one study found better outcomes when treated<ref name="pmid33369614">{{cite journal| author=Rastogi R, Sheehan MM, Hu B, Shaker V, Kojima L, Rothberg MB| title=Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions. | journal=JAMA Intern Med | year= 2021 | volume= 181 | issue= 3 | pages= 345-352 | pmid=33369614 | doi=10.1001/jamainternmed.2020.7501 | pmc=7770615 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33369614  }} </ref>. The prevalence of end-organ damage was not clear in this study.
 
===Intravenous Antihypertensive Drugs===
Shown below is a table of the IV antihypertensive drugs and their appropriate doses.<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199  }} </ref>
 
{| Class="wikitable"
! Drug
! Dose
|-
| [[Clevidipine]]
| 1 to 2 mg/h as IV infusion, max 16 mg/h
|-
| [[Enalaprilat]]
| 1.25–5 mg every 6 hrs IV
|-
| [[Fenoldopam]]
| 0.1–0.3 µg/kg per min IV infusion
|-
|[[Hydralazine]]
|10–20 mg IV
|-
|[[Nicardipine]]
|5–15 mg/h IV
|-
|[[Nitroglycerin]]
| 5–100 µg/min as IV infusion
|-
|[[Nitroprusside]]
|0.25–10 µg/kg/min as IV infusion
|-
|[[Esmolol]]
| 250–500 µg/kg/min IV bolus, then 50–100 µg/kg/min by infusion<br> May repeat bolus after 5 min or increase infusion to 300 µg/min
|-
|[[Labetalol]]
|20–80 mg IV bolus every 10 min 0.5–2.0 mg/min IV infusion
|-
|[[Phentolamine]]
|5–15 mg IV bolus
|}


It is also important that the blood pressure is lowered not too abruptly, but smoothly. The diagnosis of a hypertensive emergency is not only based on the absolute level of blood pressure, but also on the individual regular level of blood pressure before the hypertensive crisis. Individuals with a history of [[chronic (medicine)|chronic]] hypertension may not tolerate a "normal" blood pressure.
===Oral Antihypertensive Drugs===
Shown below is a table of the oral antihypertensive drugs and their appropriate doses.<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199  }} </ref>


=== Hypertensive Emergency as a Specific Term ===
{| Class="wikitable"
! Drug
! Dose
|-
|[[Captopril]]
|12.5 to 25 mg  PO or SL, repeat as needed. max dose - 50 mg PO
|-
|[[Clonidine]]
|0.1-0.2 mg PO x 1, then 0.05 to 0.1 mg/1-2 hrs. Max dose - 0.6 to 0.7 mg
|-
|[[Labetalol]]
|200 mg PO, then 200 mg/hr until desired effect. Max dose - 1200 mg
|}
* Other agents to consider include: 
# PO [[frusemide]] 20mg (repeat as necessary)
# PO [[nifedipine]] SR 30mg, single dose
# PO [[felodipine]] 5 mg, single dose


The term hypertensive emergency is primarily used as a specific term for a hypertensive crisis with a diastolic blood pressure of 120 mm Hg and above plus end organ damage (brain, cardiovascular, renal) (as described above) in contrast to hypertensive urgency where as yet no end organ damage has developed. The former requires immediate lowering of blood pressure such as with sodium nitroprusside infusions (NOT injections) while urgencies (about 3/4 of cases with diastolic blood pressure of 120 mm Hg and above) can be treated with parenteral administration (NOT oral) of labetalol or some Ca-channel blockers! The former use of oral nifedipine, a Ca-channel antagonist, has been strongly discouraged or banned because it is not absorbed in a controlled and reproducible fashion and has led to serious and fatal hypotensive problems.
===Management of Specific Hypertensive Emergencies===
{| Class="wikitable"
!Hypertensive emergencies
!Preferred agents
|-
|[[Aortic dissection]]
|[[Labetalol]], or [[nicardipine]] + [[esmolol]], or [[nitroprusside]] + [[esmolol]] or [[nitroprusside]] + IV [[metoprolol]] <br> Note: '''Administer beta blocker to control the heart rate before initiating a vasodilator''' e.g. [[nitroprusside]]
* Reduce [[blood pressure]] to '''120 mmHg''' within 20 minutes  with protection against reflex tachycardia.<ref name="pmid12748199">{{cite journal| author=Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al.| title=The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. | journal=JAMA | year= 2003 | volume= 289 | issue= 19 | pages= 2560-72 | pmid=12748199 | doi=10.1001/jama.289.19.2560 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12748199  }} </ref>
|-
|[[Pulmonary edema|Acute pulmonary edema]] / systolic dysfunction
|Nitroglycerin + (Nicardipine or, fenoldopam, or nitroprusside) + loop diuretic
|-
|[[Pulmonary edema|Acute pulmonary edema]] / diastolic dysfunction
|Low-dose Nitroglycerin + ([[esmolol]], [[metoprolol]], [[labetalol]], or [[verapamil]]) + loop diuretic
|-
|[[Acute coronary syndrome]]
|[[Nitroglycerin]] + (labetalol or esmolol)
|-
|Hypertensive emergency with acute or chronic [[renal failure]]
|[[Nicardipine]] or [[fenoldopam]]
|-
|[[Hypertensive encephalopathy]]
|[[Nicardipine]], [[labetalol]], [[fenoldopam]] <br> Note: the [[blood pressure]] should not be lowered by more than 25%
|-
|[[Pre-eclampsia]] / [[eclampsia]]
|[[Labetalol]] or [[nicardipine]]
|-
|[[Sympathetic crisis]] / [[cocaine overdose]]
|[[Benzodiazepine]] + ([[verapamil]], [[diltiazem]], or [[nicardipine]]) <br> Note: Beta blockers should '''NOT''' be administered alone to prevent un-opposed alpha-adrenergic stimulation
|-
|[[Cerebrovascular accident]]
|[[Nicardipine]], [[labetalol]], [[fenoldopam]], or [[clevidipine]] <br> Note: An expert's judgement is required to determine if the [[blood pressure]] should be lowered.
|-
|Withdrawal of antihypertensive therapy e.g. [[clonidine]] or [[propanolol]]
|Re-administer the discontinued drug;  [[phentolamine]], [[nitroprusside]], or [[labetalol]], if necessary
|}


=== Hypertensive Emergency as a Generic Term ===
==Prognosis==
Patient may be at risk of readmission<ref name="pmid30571563/">{{cite journal| author=Kumar N, Simek S, Garg N, Vaduganathan M, Kaiksow F, Stein JH | display-authors=etal| title=Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency. | journal=Hypertension | year= 2019 | volume= 73 | issue= 1 | pages= 60-67 | pmid=30571563/ | doi=10.1161/HYPERTENSIONAHA.118.11691 | pmc=6310036 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30571563  }} </ref><ref name="pmid30571571">{{cite journal| author=Agarwal R| title=Rehospitalization Rates in Hypertensive Emergency. | journal=Hypertension | year= 2019 | volume= 73 | issue= 1 | pages= 49-51 | pmid=30571571 | doi=10.1161/HYPERTENSIONAHA.118.11789 | pmc=6883922 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30571571  }} </ref>.


Sometimes, although not very often, the term hypertensive emergency is also used as a generic term, comprising both hypertensive emergency as a specific term for a serious and urgent condition of elevated blood pressure and hypertensive urgency as a specific term of a less serious and less urgent condition (the terminology hypertensive crisis is usually used in this sense).
==References==
{{reflist|2}}


== Related Chapters ==
== Related Chapters ==
* [[Malignant hypertension]]
* [[Malignant hypertension|Malignant Hypertension]]
* [[Hypertension]]
* [[Hypertension]]
* [[Hypertensive retinopathy]]
* [[Hypertensive retinopathy|Hypertensive Retinopathy]]


[[Category:Cardiology]]
[[Category:Cardiology]]

Latest revision as of 19:44, 28 February 2024



Resident
Survival
Guide

WikiDoc Resources for Hypertensive crisis

Articles

Most recent articles on Hypertensive crisis

Most cited articles on Hypertensive crisis

Review articles on Hypertensive crisis

Articles on Hypertensive crisis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hypertensive crisis

Images of Hypertensive crisis

Photos of Hypertensive crisis

Podcasts & MP3s on Hypertensive crisis

Videos on Hypertensive crisis

Evidence Based Medicine

Cochrane Collaboration on Hypertensive crisis

Bandolier on Hypertensive crisis

TRIP on Hypertensive crisis

Clinical Trials

Ongoing Trials on Hypertensive crisis at Clinical Trials.gov

Trial results on Hypertensive crisis

Clinical Trials on Hypertensive crisis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hypertensive crisis

NICE Guidance on Hypertensive crisis

NHS PRODIGY Guidance

FDA on Hypertensive crisis

CDC on Hypertensive crisis

Books

Books on Hypertensive crisis

News

Hypertensive crisis in the news

Be alerted to news on Hypertensive crisis

News trends on Hypertensive crisis

Commentary

Blogs on Hypertensive crisis

Definitions

Definitions of Hypertensive crisis

Patient Resources / Community

Patient resources on Hypertensive crisis

Discussion groups on Hypertensive crisis

Patient Handouts on Hypertensive crisis

Directions to Hospitals Treating Hypertensive crisis

Risk calculators and risk factors for Hypertensive crisis

Healthcare Provider Resources

Symptoms of Hypertensive crisis

Causes & Risk Factors for Hypertensive crisis

Diagnostic studies for Hypertensive crisis

Treatment of Hypertensive crisis

Continuing Medical Education (CME)

CME Programs on Hypertensive crisis

International

Hypertensive crisis en Espanol

Hypertensive crisis en Francais

Business

Hypertensive crisis in the Marketplace

Patents on Hypertensive crisis

Experimental / Informatics

List of terms related to Hypertensive crisis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Synonyms and keywords: Hypertensive emergency; hypertensive urgency; severe hypertension

Overview

Hypertensive crisis is a term used to describe a severe elevation in the blood pressure which may or may not be associated with end-organ damage.[1] Noncompliance with antihypertensive medications is the most common cause of hypertensive crisis.[2] Hypertensive crisis includes both hypertensive emergency and hypertensive urgency. Hypertensive urgency is the severe elevation in the blood pressure without any evidence of acute end-organ damage. Hypertensive emergency mostly falls into stage 2 of hypertension. It is usually the severe elevation in the blood pressure (systolic blood pressure >180 mm Hg, or diastolic blood pressure >120 mm Hg) complicated by acute end-organ dysfunction, such as hypertensive encephalopathy, eclampsia, dissecting aortic aneurysm, acute left ventricular failure with pulmonary edema, acute myocardial infarction, acute renal failure, or symptomatic microangiopathic hemolytic anemia.[3] The treatment of hypertensive urgency requires a gradual reduction in blood pressure over 24 to 48 hours. In hypertensive emergency, the treatment should be targeted to reduce the blood pressure by not more than 25% within the first hour; when blood pressure is stable, it should be reduced to 160/100-110 mmHg within the next 2 to 6 hours.[3]

Classification

Hypertensive crisis can be further classified as hypertensive urgency and hypertensive emergency based on either the absence or presence of acute end-organ damage.[1]

 
 
Hypertensive crisis
Acute elevation of blood pressure
- Systolic blood pressure >180 mm Hg, or
- Diastolic blood pressure >120 mm Hg
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypertensive emergency
Evidence of end organ damage
 
Hypertensive urgency
No evidence of end organ damage
 

Hypertensive Urgency

Hypertensive urgency is an acute severe elevation in the blood pressure without any evidence of acute end-organ damage.

Hypertensive Emergency

Hypertensive emergency mostly falls into stage 2 of hypertension (systolic blood pressure greater >160 mm Hg or diastolic blood pressure >100 mm Hg). It is usually an acute severe elevation in the blood pressure (systolic blood pressure >180 mm Hg, or diastolic blood pressure >120 mm Hg) complicated by acute end-organ dysfunction, such as hypertensive encephalopathy, eclampsia, dissecting aortic aneurysm, acute left ventricular failure with pulmonary edema, acute myocardial infarction, acute renal failure, or symptomatic microangiopathic hemolytic anemia.[3]

Hypertensive Emergency as a Specific Term

The term hypertensive emergency is primarily used as a specific term for a hypertensive crisis with a diastolic blood pressure of 120 mm Hg and above plus end organ damage (brain, cardiovascular, renal) (as described above) in contrast to hypertensive urgency where as yet no end organ damage has developed. The former requires immediate lowering of blood pressure such as with sodium nitroprusside infusions (NOT injections) while urgencies (about 3/4 of cases with diastolic blood pressure of 120 mm Hg and above) can be treated with parenteral administration (NOT oral) of labetalol or some calcium channel blockers. The former use of oral nifedipine, a calcium channel antagonist, has been strongly discouraged or banned because it is not absorbed in a controlled and reproducible fashion and has led to serious and fatal hypotensive problems.

Hypertensive Emergency as a Generic Term

Sometimes, although not very often, the term hypertensive emergency is also used as a generic term, comprising both hypertensive emergency as a specific term for a serious and urgent condition of elevated blood pressure and hypertensive urgency as a specific term of a less serious and less urgent condition (the terminology hypertensive crisis is usually used in this sense).

Causes

Life Threatening Causes

Hypertensive crisis is a life-threatening condition and must be treated as such irrespective of the cause.

Common Causes

Causes by Organ System

Cardiovascular No underlying causes
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic No underlying causes
Drug Side Effect Axitinib, Naphazoline, Naratriptan, Phendimetrazine, Sorafenib , Ziv-aflibercept
Ear Nose Throat No underlying causes
Endocrine No underlying causes
Environmental No underlying causes
Gastroenterologic No underlying causes
Genetic No underlying causes
Hematologic No underlying causes
Iatrogenic No underlying causes
Infectious Disease No underlying causes
Musculoskeletal/Orthopedic No underlying causes
Neurologic No underlying causes
Nutritional/Metabolic No underlying causes
Obstetric/Gynecologic No underlying causes
Oncologic No underlying causes
Ophthalmologic No underlying causes
Overdose/Toxicity No underlying causes
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte No underlying causes
Rheumatology/Immunology/Allergy No underlying causes
Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order

List the causes of the disease in alphabetical order. You may need to list across the page, as seen here

Treatment

Management is directed by clinical practice guidelines[4]:

  • "Hypertensive emergencies are defined as severe elevations in BP (>180/120 mm Hg) associated with evidence of new or worsening target organ damage."
  • "hypertensive urgencies are situations associated with severe BP elevation in otherwise stable patients without acute or impending change in target organ damage or dysfunction....Reinstitution or intensification of antihypertensive drug therapy and treatment of anxiety as applicable. There is no indication for referral to the emergency department, immediate reduction in BP in the emergency department, or hospitalization for such patients"

Provide acute therapy for hypertensive emergency

For patients with end-organ damage and SBP >179 and DBP >119, the patient is suffering from hypertensive emergency. These patients should be admitted to the ICU and receive parenteral antihypertensive medications to avoid fluctuating drug levels from the oral or intramuscular routes. The immediate goal is to decrease the DBP by 10-15 % or to approximately 110 mm Hg in the first 30-60 minutes, then when blood pressure is stable, reduce to 160/100-110 mmHg within the next 2-6 hours. Start the treatment with short-acting IV antihypertensive drugs depending on the type of the end-organ damage. Keep close monitoring to the blood pressure and in severely ill patients intra-arterial blood pressure monitoring is used. Once the blood pressure is stable we shift to oral antihypertensive drugs. When the patient is stable and the blood pressure is well tolerated, reduce the blood pressure to normal within 24-48 hours.

Increase chronic therapy for hypertensive urgency

Per the 2018 multi-society practice guideline:

  • "hypertensive urgencies ... are treated by reinstitution or intensification of antihypertensive drug therapy"[4]

Evidence for this approach exists[5][6]

Intensifying treatment of hospitalized patients in the absence of emergency may worse outcomes, at least for noncardiac patients[7][8]. However, one study found better outcomes when treated[7]. The prevalence of end-organ damage was not clear in this study.

Intravenous Antihypertensive Drugs

Shown below is a table of the IV antihypertensive drugs and their appropriate doses.[3]

Drug Dose
Clevidipine 1 to 2 mg/h as IV infusion, max 16 mg/h
Enalaprilat 1.25–5 mg every 6 hrs IV
Fenoldopam 0.1–0.3 µg/kg per min IV infusion
Hydralazine 10–20 mg IV
Nicardipine 5–15 mg/h IV
Nitroglycerin 5–100 µg/min as IV infusion
Nitroprusside 0.25–10 µg/kg/min as IV infusion
Esmolol 250–500 µg/kg/min IV bolus, then 50–100 µg/kg/min by infusion
May repeat bolus after 5 min or increase infusion to 300 µg/min
Labetalol 20–80 mg IV bolus every 10 min 0.5–2.0 mg/min IV infusion
Phentolamine 5–15 mg IV bolus

Oral Antihypertensive Drugs

Shown below is a table of the oral antihypertensive drugs and their appropriate doses.[3]

Drug Dose
Captopril 12.5 to 25 mg PO or SL, repeat as needed. max dose - 50 mg PO
Clonidine 0.1-0.2 mg PO x 1, then 0.05 to 0.1 mg/1-2 hrs. Max dose - 0.6 to 0.7 mg
Labetalol 200 mg PO, then 200 mg/hr until desired effect. Max dose - 1200 mg
  • Other agents to consider include:
  1. PO frusemide 20mg (repeat as necessary)
  2. PO nifedipine SR 30mg, single dose
  3. PO felodipine 5 mg, single dose

Management of Specific Hypertensive Emergencies

Hypertensive emergencies Preferred agents
Aortic dissection Labetalol, or nicardipine + esmolol, or nitroprusside + esmolol or nitroprusside + IV metoprolol
Note: Administer beta blocker to control the heart rate before initiating a vasodilator e.g. nitroprusside
  • Reduce blood pressure to 120 mmHg within 20 minutes with protection against reflex tachycardia.[3]
Acute pulmonary edema / systolic dysfunction Nitroglycerin + (Nicardipine or, fenoldopam, or nitroprusside) + loop diuretic
Acute pulmonary edema / diastolic dysfunction Low-dose Nitroglycerin + (esmolol, metoprolol, labetalol, or verapamil) + loop diuretic
Acute coronary syndrome Nitroglycerin + (labetalol or esmolol)
Hypertensive emergency with acute or chronic renal failure Nicardipine or fenoldopam
Hypertensive encephalopathy Nicardipine, labetalol, fenoldopam
Note: the blood pressure should not be lowered by more than 25%
Pre-eclampsia / eclampsia Labetalol or nicardipine
Sympathetic crisis / cocaine overdose Benzodiazepine + (verapamil, diltiazem, or nicardipine)
Note: Beta blockers should NOT be administered alone to prevent un-opposed alpha-adrenergic stimulation
Cerebrovascular accident Nicardipine, labetalol, fenoldopam, or clevidipine
Note: An expert's judgement is required to determine if the blood pressure should be lowered.
Withdrawal of antihypertensive therapy e.g. clonidine or propanolol Re-administer the discontinued drug; phentolamine, nitroprusside, or labetalol, if necessary

Prognosis

Patient may be at risk of readmission[9][10].

References

  1. 1.0 1.1 "The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)". Arch Intern Med. 153 (2): 154–83. 1993. PMID 8422206. Unknown parameter |month= ignored (help)
  2. 2.0 2.1 Stewart, DL.; Feinstein, SE.; Colgan, R. (2006). "Hypertensive urgencies and emergencies". Prim Care. 33 (3): 613–23, v. doi:10.1016/j.pop.2006.06.001. PMID 17088151. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 3.2 3.3 3.4 3.5 Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199.
  4. 4.0 4.1 Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C; et al. (2018). "2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Hypertension. 71 (6): e13–e115. doi:10.1161/HYP.0000000000000065. PMID 29133356.
  5. Zeller KR, Von Kuhnert L, Matthews C (1989). "Rapid reduction of severe asymptomatic hypertension. A prospective, controlled trial". Arch Intern Med. 149 (10): 2186–9. PMID 2679473.
  6. "Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg". JAMA. 202 (11): 1028–34. 1967. PMID 4862069.
  7. 7.0 7.1 Rastogi R, Sheehan MM, Hu B, Shaker V, Kojima L, Rothberg MB (2021). "Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions". JAMA Intern Med. 181 (3): 345–352. doi:10.1001/jamainternmed.2020.7501. PMC 7770615 Check |pmc= value (help). PMID 33369614 Check |pmid= value (help).
  8. Anderson TS, Jing B, Auerbach A, Wray CM, Lee S, Boscardin WJ; et al. (2019). "Clinical Outcomes After Intensifying Antihypertensive Medication Regimens Among Older Adults at Hospital Discharge". JAMA Intern Med. 179 (11): 1528–1536. doi:10.1001/jamainternmed.2019.3007. PMC 6705136 Check |pmc= value (help). PMID 31424475.
  9. Kumar N, Simek S, Garg N, Vaduganathan M, Kaiksow F, Stein JH; et al. (2019). "Thirty-Day Readmissions After Hospitalization for Hypertensive Emergency". Hypertension. 73 (1): 60–67. doi:10.1161/HYPERTENSIONAHA.118.11691. PMC 6310036. PMID 30571563/ Check |pmid= value (help).
  10. Agarwal R (2019). "Rehospitalization Rates in Hypertensive Emergency". Hypertension. 73 (1): 49–51. doi:10.1161/HYPERTENSIONAHA.118.11789. PMC 6883922 Check |pmc= value (help). PMID 30571571.

Related Chapters


Template:WikiDoc Sources